Clinics in Oregon
By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed. Last verified
What Oregon law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and listings with their verification status.
Oregon at a glance
- Pharmacy regulator
- Oregon Board of Pharmacy
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async allowed
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Clinics serving Oregon
No verified clinics serving Oregon are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.
Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.
Run a pharmacy, clinic, or telehealth service? Apply for a listing.
Peptide access rules in Oregon
Yes. An Oregon resident can obtain FDA approved peptides such as semaglutide and tirzepatide from an Oregon-licensed prescriber. ORS 677.494 lets physicians and physician associates use synchronous or asynchronous telemedicine to establish the provider-patient relationship and prescribe, and Oregon Medical Board policy says treatment based solely on an online questionnaire without individualized review and assessment is not an acceptable standard of care. A resident can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy registered with the Oregon Board of Pharmacy as an in-state or out-of-state drug outlet. The Board of Pharmacy regulates compounding through OAR chapter 855, division 183 (adopted June 17, 2026), which incorporates USP standards and follows the FDA 503A bulks framework rather than a separate Oregon list. [1] [3] [4] [6] [7] [8] [10]
Compounded GLP-1 access in Oregon
Telehealth GLP-1 patients should confirm the dispensing pharmacy appears in the Board of Pharmacy license lookup. [1] [11]
Research use only sellers in Oregon
ORS chapter 689 restricts dispensing of prescription drugs to registered pharmacies and licensed practitioners, and a seller of "research use only" injectable peptides to Oregon consumers is not a registered drug outlet. Oregon's Unlawful Trade Practices Act, ORS 646.608(1)(e), makes it unlawful in the course of business to represent that goods have characteristics, uses, or benefits that they do not have. [6] [9] [12]
How to check a clinic in Oregon
- Confirm the prescribing clinician's license with the Oregon medical or nursing board.
- Ask which pharmacy compounds or dispenses the peptide and check it in the Oregon Board of Pharmacy license lookup. [1] [6] [7] [8] [10]
- Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Oregon. [6] [9] [12]
Common questions in Oregon
Can I get a GLP-1 prescription in Oregon through telemedicine?
Yes. ORS 677.494 lets a physician or physician associate use telemedicine to establish the provider-patient relationship and prescribe drugs for a patient located in Oregon. The statute's definition of telemedicine covers both real-time and asynchronous technologies, so that statute does not require a live visit. The Oregon Medical Board's policy statement says treatment based solely on an online questionnaire without individualized review and assessment is not an acceptable standard of care. [3] [4]
Can an out-of-state telehealth doctor treat me in Oregon?
Only if the physician holds a full Oregon license or an Oregon license for the practice of medicine across state lines under OAR 847-025. Oregon is not a member of the Interstate Medical Licensure Compact, so a compact license does not cover Oregon patients. Look the prescriber up in the Oregon Medical Board license search before paying. [2] [5] [13]
Sources
- [1]Oregon Board of Pharmacy
- [2]Oregon Medical Board (license search and board policies)
- [3]ORS 677.494, Telemedicine; where practice occurs (ORS chapter 677)
- [4]Oregon Medical Board Statement of Philosophy: Telemedicine (amended April 4, 2024)
- [5]Oregon Administrative Rules chapter 847, division 25, Licensure to Practice Medicine Across State Lines (Oregon Medical Board)
- [6]ORS chapter 689, Pharmacists; Drug Outlets; Drug Sales
- [7]Oregon Administrative Rule 855-041-1060, Non-Resident Pharmacies
- [8]Oregon Administrative Rules chapter 855, division 183, Drug Compounding (Oregon Board of Pharmacy, effective June 17, 2026)
- [9]ORS 646.608, Additional unlawful business, trade practices (Unlawful Trade Practices Act)
- [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA